Earnings Call · Q2 FY2022·2022-08-04

Q2 22EPS -5.62%·Rev n/aQ1 22EPS -49.15%·Rev n/aQ4 21EPS -95.45%·Rev n/aQ3 21EPS -20.00%·Rev n/a⚠ consensus missing

NEUROCRINE BIOSCIENCES INC NBIX

Todd Tushla — Vice President of Investor Relations

Kevin Gorman — Chief Executive Officer

Matt Abernethy — Chief Financial Officer

Eric Benevich — Chief Commercial Officer

Eiry Roberts — Chief Medical Officer

+8.5%1d on move date+8.6% vs SPY3d+12.2%5d+9.3%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more NBIX calls or request research access.

More NBIX calls Browse calls Request research access